In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...

Learn about the changing trend in pre exposure prophylaxis medication prescription for HIV patients in the US over the past decade. Pre-exposure prophylaxis (PrEP) with antiretroviral medications is ...

Introduction Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products ...

Health Minister Jo Etienne Abela says Malta is aligned with UNAIDS goals to end AIDS as a public health threat by 2030 ...

HIV prevention medication Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) have been made free, the government said. The Minister for Health and Active Ageing, Jo Etienne ...

MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce ...

MONTRÉAL, March 5, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce ...